Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The COVID-19 crisis has primed governments to invest substantially in pandemic preparedness, a lesson that must be replicated to fight the alarming growth of drug resistance globally, write Manica Balasegaram* and Yogendra Kumar Gupta**.